Clinical trial
A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
NCT00406393 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase III Randomized, Multicenter Trial Comparing Sirolimus/Tacrolimus With Tacrolimus/Methotrexate as Graft-versus-Host Disease (GVHD) Prophylaxis After HLA-Matched, Related Peripheral Blood Stem Cell Transplantation (BMT CTN #0402)
- Lead sponsor
- Medical College of Wisconsin
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 30, 2006
- Completion date
- October 31, 2015
- Enrollment
- 304 (actual)
- Sites
- 24
Conditions
As the registry lists them; a condition with its own page is linked.
leukemia, lymphocytic, acute, leukemia, myelocytic, acute, leukemia, myeloid, chronic, myelodysplastic syndromes